The secretory output from VAT and PAT of patients with type 2 diabetes and/or obesity contains high amounts of VEGF and stimulates proliferation and VEGF-R1/2 expression as compared to SAT. Here, VEGFA is linked to obesity due to melanocortin 4 receptor deficiency.